Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients

S. Vachatova, C. Andrys, J. Krejsek, M. Salavec, K. Ettler, V. Rehacek, E. Cermakova, A. Malkova, Z. Fiala, L. Borska,

. 2016 ; 2016 (-) : 5380792. [pub] 20161221

Jazyk angličtina Země Egypt

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17013301

The presented article studies the role of selected inflammatory and anti-inflammatory serum markers of psoriatic patients in the pathogenesis of metabolic syndrome (MS) and psoriasis. The study is based on the comparison between the group of psoriatic patients (74) and the control group (65). We found significantly higher BMI (p < 0.05) and diastolic blood pressure (p < 0.05) in the psoriatic patients. The values of waist circumference and BMI were significantly higher (p < 0.05) in the male patients compared to the men in the control group. The analysis revealed significantly higher CRP (p < 0.001), Lp-PLA2 (p < 0.001), leptin (p < 0.01), and resistin (p < 0.01) levels in the psoriatic patients. Significantly higher levels of CRP (p < 0.01), Lp-PLA2 (p < 0.001), leptin (p < 0.01), and resistin (p < 0.05) were found in the patients with MS compared to the controls with MS. The level of adiponectin was significantly lower (p < 0.01) in the patients with MS. Finally, we found significantly higher level of Lp-PLA2 (p < 0.001) in the group of patients without MS compared to the controls without MS. In conclusion, observed inflammatory and anti-inflammatory markers (CRP, adiponectin, leptin, resistin, and Lp-PLA2) are involved in both pathogenesis of MS and pathogenesis of psoriasis. The level of Lp-PLA2 indicates the presence of subclinical atherosclerosis (cardiovascular risk) in psoriatic patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013301
003      
CZ-PrNML
005      
20170502095252.0
007      
ta
008      
170413s2016 ua f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2016/5380792 $2 doi
035    __
$a (PubMed)28097156
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ua
100    1_
$a Vachatova, Simona $u Department of Dermatology and Venereology, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech Republic.
245    10
$a Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients / $c S. Vachatova, C. Andrys, J. Krejsek, M. Salavec, K. Ettler, V. Rehacek, E. Cermakova, A. Malkova, Z. Fiala, L. Borska,
520    9_
$a The presented article studies the role of selected inflammatory and anti-inflammatory serum markers of psoriatic patients in the pathogenesis of metabolic syndrome (MS) and psoriasis. The study is based on the comparison between the group of psoriatic patients (74) and the control group (65). We found significantly higher BMI (p < 0.05) and diastolic blood pressure (p < 0.05) in the psoriatic patients. The values of waist circumference and BMI were significantly higher (p < 0.05) in the male patients compared to the men in the control group. The analysis revealed significantly higher CRP (p < 0.001), Lp-PLA2 (p < 0.001), leptin (p < 0.01), and resistin (p < 0.01) levels in the psoriatic patients. Significantly higher levels of CRP (p < 0.01), Lp-PLA2 (p < 0.001), leptin (p < 0.01), and resistin (p < 0.05) were found in the patients with MS compared to the controls with MS. The level of adiponectin was significantly lower (p < 0.01) in the patients with MS. Finally, we found significantly higher level of Lp-PLA2 (p < 0.001) in the group of patients without MS compared to the controls without MS. In conclusion, observed inflammatory and anti-inflammatory markers (CRP, adiponectin, leptin, resistin, and Lp-PLA2) are involved in both pathogenesis of MS and pathogenesis of psoriasis. The level of Lp-PLA2 indicates the presence of subclinical atherosclerosis (cardiovascular risk) in psoriatic patients.
650    _2
$a 1-alkyl-2-acetylglycerofosfocholinesterasa $x krev $7 D043203
650    _2
$a adiponektin $x krev $7 D052242
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a krevní tlak $7 D001794
650    _2
$a index tělesné hmotnosti $7 D015992
650    _2
$a C-reaktivní protein $x metabolismus $7 D002097
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a leptin $x krev $7 D020738
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a metabolický syndrom $x krev $x imunologie $x patologie $7 D024821
650    _2
$a lidé středního věku $7 D008875
650    _2
$a psoriáza $x krev $x imunologie $x patologie $7 D011565
650    _2
$a resistin $x krev $7 D052243
650    _2
$a obvod pasu $7 D055105
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Andrýs, Ctirad $u Institute of Clinical Immunology and Allergology, Faculty of Medicine in Hradec Kralove, Charles University in Prague, 50038 Hradec Kralove, Czech Republic. $7 mzk2008430528
700    1_
$a Krejsek, Jan $u Institute of Clinical Immunology and Allergology, Faculty of Medicine in Hradec Kralove, Charles University in Prague, 50038 Hradec Kralove, Czech Republic.
700    1_
$a Salavec, Miloslav $u Department of Dermatology and Venereology, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech Republic.
700    1_
$a Ettler, Karel $u Department of Dermatology and Venereology, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech Republic.
700    1_
$a Rehacek, Vit $u Department of Transfusion Medicine, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech Republic.
700    1_
$a Cermakova, Eva $u Department of Medical Biophysics, Faculty of Medicine in Hradec Kralove, Charles University in Prague, 50038 Hradec Kralove, Czech Republic.
700    1_
$a Malkova, Andrea $u Institute of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University in Prague, 50038 Hradec Kralove, Czech Republic.
700    1_
$a Fiala, Zdenek $u Institute of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University in Prague, 50038 Hradec Kralove, Czech Republic.
700    1_
$a Borska, Lenka $u Institute of Pathological Physiology, Faculty of Medicine in Hradec Kralove, Charles University in Prague, 50038 Hradec Kralove, Czech Republic.
773    0_
$w MED00186351 $t Journal of immunology research $x 2314-7156 $g Roč. 2016, č. - (2016), s. 5380792
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28097156 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170502095618 $b ABA008
999    __
$a ok $b bmc $g 1199766 $s 974079
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 2016 $c - $d 5380792 $e 20161221 $i 2314-7156 $m Journal of immunology research $n J. immunol. res. $x MED00186351
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Možnosti archivace